|
KMID : 0882420140870040501
|
|
Korean Journal of Medicine
2014 Volume.87 No. 4 p.501 ~ p.504
|
|
|
Hypoglycemic Coma in a Patient with Metastatic Renal Cell Carcinoma Treated with Sunitinib
|
|
Cho Me-Young
Shim Hyeok
Park Moo-Rim
|
|
|
Abstract
|
|
|
|
We present a patient with type 2 diabetes mellitus and metastatic renal cell carcinoma who developed severe hypoglycemia and metabolic encephalopathy after sunitinib treatment. Sunitinib, a multi-target tyrosine kinase inhibitor, is used to treat metastatic renal cell carcinoma. Sunitinib-induced hypoglycemia has been reported and there are rare case reports of severe hypoglycemia due to sunitinib. Therefore, glycemic control should be monitored closely in diabetic patients treated with sunitinib.
|
|
|
KEYWORD
|
|
|
Sunitinib, Hypoglycemia, Metabolic encephalopathy
|
|
|
FullTexts / Linksout information
|
|
|
|
|
Listed journal information
|
|
  
|